Skip to main content
Clinical Trials/NCT07733284
NCT07733284RecruitingPhase 1

Safety and Feasibility of Remote Walking Exercise for Cognitive Improvement in Persons With TBI

Kessler Foundation1 site in 1 country40 target enrollmentStarted: April 15, 2026Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor
Enrollment
40
Locations
1
Primary Endpoint
Adverse Events

Study Overview

Brief Summary

The purpose of this research study is to investigate the effects of a home-based 3-month long walking exercise program on cognitive (thinking) performance in persons with TBI. As a participant, you will complete this 3-month exercise program now or after a 3-month wait period.

Detailed Description

This study involves no in-person visits to Kessler Foundation and takes place at home.

The first study activity will last about 1 hour in total and will involve using videoconferencing software (Zoom) to take tests of thinking (e.g., matching shapes and number, learning a list of words). You will then complete several brief questionnaires about everyday activities and TBI symptoms over the computer.

You will then be randomly picked (like the flip of a coin) by a computer to participate in one of two groups. You will have a 50/50 chance of being placed in either group.

One group will complete 3-months of walking exercise at home. The exercise program is based on activity guidelines for people with TBI and will be monitored by a trained exercise leader. You will be asked to walk 3 times per week. The first two weeks will require you to walk for 10 minutes at a time, and that duration will increase throughout the 3-months. You will have a dedicated trainer to help get started, answer questions, and support you throughout the programs. You will have regular meetings with this trainer by video conference (Zoom). You will be sent a FitBit to wear on your wrist while exercising to track your steps, and that you will be allowed to keep when the study ends.

The other group will stick to a regular routine during this 3-month period (i.e., wait-list group).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Definitive TBI diagnosis at least 1 year prior, verified by medical records
  • Self-report problems with thinking skills since the TBI diagnosis (e.g., processing information, learning or remembering, organizing, multitasking)
  • Between the ages of 18 and 65
  • Access to internet and email
  • Fluent in English
  • Can walk at a brisk pace without using an assistive device
  • Not fallen due to mobility issues from their TBI in the past 6 months
  • Do not currently meet public health guidelines for physical activity
  • Have problems with thinking performance

Exclusion Criteria

  • I currently have uncontrolled major depression
  • I have a history of schizophrenia, bipolar disorder I or II, or substance-abuse disorders
  • I am regularly taking medications that can affect my thinking, such as antipsychotics or benzodiazepines. Study staff will review my medications to determine if I am taking any that would make me ineligible for this study
  • I have known/diagnosed cardiovascular disease including uncontrolled hypertension, diabetes, or kidney disease
  • I am unable to make everyday decisions on my own

Outcomes

Primary Outcomes

Adverse Events

Time Frame: Through study completion, which is 3 months for intervention and 6 months for wait list.

Safety will be primarily measured as adverse events, specifically during the remote walking intervention.

Adherence

Time Frame: Through study completion, which is 3 months for intervention and 6 months for wait list.

Adherence is measured as the number of exercise sessions attended compared to the number of total sessions prescribed.

Compliance

Time Frame: Through study completion, which is 3 months for intervention and 6 months for wait list.

Compliance will be measured as the number of exercise sessions completed as prescribed (i.e., intensity and duration).

Secondary Outcomes

  • Processing Speed(Baseline and follow-up (12-weeks post-baseline))
  • Learning/Memory(Baseline and follow-up (12-weeks post-baseline))
  • Executive function(Baseline and follow-up (12-weeks post-baseline))

Investigators

Sponsor
Kessler Foundation
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Carly Wender

Principal Investigator

Kessler Foundation

Study Sites (1)

Loading locations...

Similar Trials

Home-Based Walking for Thinking Skills in... | Clinical Trial